Title: the bell-- LegoChem presented its technology in World ADC Summit

Publication: the bell/ Dong Hee Kim

Date: 29 October 2015

Summary

• As LegoChem was invited to present its original technology at the World ADC Summit 2015, it ranges with global companies who are spearheading the research and development of ADC.

• LegoChem received attention because of its innovative technology of utilizing linkers and toxins to overcome existing problems with ADC.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).